Now streaming and on DVD: June Squibb lifts 'Thelma' in more ways than one
In the “grandma gets scammed” comedy, June Squibb plays a 93-year-old who sends $10,000 in cash to con artists because she’s ...
Cobenfy Approval Brings 20% Upside To Bristol Myers Squibb Stock
This is a big approval for the company, given that Cobenfy doesn’t have the classic side effects seen in other antipsychotic ...
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with ...
Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
Dividend investing has become increasingly popular over time, as generating regular income remains a key focus for investors.
Nicolas Cage, Colman Domingo and June Squibb Among Newport Beach Film Festival Honorees
Additional 2024 honorees include Joan Chen, June Squibb, Diane Warren, Marianne Jean-Baptiste and George MacKay along with 10 ...
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia ...
IGM Biosciences Shares Fall on Strategic Pivot to Autoimmunity, New CEO
As part of this shift in focus, Schwarzer stepped down as CEO, with Mary Beth Harler appointed as his replacement. Harler joined IGM in 2021 as president of autoimmunity and inflammation following an ...
FierceBiotech15m
IGM completes pivot from cancer to autoimmune, shaking up C-suite and hinting at layoffs
IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. | IGM Biosciences ended last year ...
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by ...
Outpatient CAR-T Cancer Therapy Can Be Safe, Effective
The new study included 82 patients whose large B-cell lymphoma had failed to respond to treatment or had returned after a ...
Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)
Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...